Did you know that immune checkpoint inhibitors have become a key option for muscle-invasive bladder cancer and locally advanced/metastatic bladder cancer?
This @RedMedEd CME activity covers emerging immunotherapies (and how to use them) and other important advances in BC management.
ALT A doctor in a white coat with a stethoscope around her neck is sitting at a wooden table. She is writing notes in a notebook, with an open laptop beside her.
Free @RedMedEd CE opportunity! How can clinicians integrate ctDNA, ICIs, and ADCs into the management of muscle-invasive bladder cancer?
Learn from experts @ERPlimackMD@siadaneshmand and Colleen H. Tetzlaff, MHS, PA-C on emerging biomarkers, personalized treatment strategies, and the importance of a multidisciplinary approach to MIBC care.
APPs: level up your bladder cancer management game . Test your knowledge of treatment approaches in our game show–style CE activity. Rack up points, earn credit, and sharpen your management skills! With @BladderCancerUS and Colleen Tetzlaff @Onc_PA_Mom
Clinical Callout, our CME-accredited activity on developments in bladder cancer patient care, provides downloadable practice tools—including several developed by our partner @BladderCancerUS —to help you optimize care for your bladder cancer patients.
Presented by lymphoma experts and featuring patient cases, @lymphoma Lymphoma Rounds Symposium series provides information on new therapies and strategies for lymphoma care. Each activity in this series explores an issue central to lymphoma management.
Quick, case-based myeloma CME—available now. Make sure your approach to relapsed myeloma is keeping pace with recent advances in our newest Ace the Case activities with @SurbhiSidanaMD#mmsm
How can clinicians integrate ctDNA, ICIs, and ADCs into the management of muscle-invasive bladder cancer?
Continuing education from experts @ERPlimackMD@siadaneshmand and Colleen H. Tetzlaff, MHS, PA-C on emerging biomarkers, personalized treatment strategies, and the importance of a multidisciplinary approach to MIBC care.
@RedMedEd
ALT A medical professional in a white coat and teal scrubs is seated while writing in a notebook. She is holding a tablet in her other hand and wearing glasses. A stethoscope and a blood pressure cuff are placed on the table in front of her. Her expression appears focused and engaged.
⚠️ CDC estimates that nearly 500,000 American suffer from Alpha-gal syndrome, with emerging evidence suggesting that number is potentially in the millions.
“We intend to bring the same urgency, innovation, and scientific rigor to Alpha-gal syndrome that we are to Lyme disease.” —@SecKennedy
Think you’re up to date on the AEs associated with bladder cancer immunotherapy?
Find out in this game-based CME activity developed for APPs, nurses, and other HCPs who treat bladder cancer. @RedMedEd
31% of patients needed to travel by air to be diagnosed with amyloid. @SLentzsch sharing key lessons for all doctors to have their clinical hats on to avoid missing this diagnosis ! #mmsm
Did you know that immune checkpoint inhibitors have become a key option for muscle-invasive bladder cancer and locally advanced/metastatic bladder cancer?
This @RedMedEd CME activity covers emerging immunotherapies (and how to use them) and other important advances in BC management.
ALT A doctor in a white coat with a stethoscope around her neck is sitting at a wooden table. She is writing notes in a notebook, with an open laptop beside her.
ALT Alt text: Image with a purple background displaying steps leading to a peak. The text "Managing Immunotherapy-Related Toxicities in Bladder Cancer" appears at the top. Overlaid are bold words "SCALE BAIL or FAIL." A hand holds a smartphone showing a quiz question. BCAN and PA logos are present at the bottom.